Literature DB >> 18992603

Distal biliary malignancy.

Gregory Veillette1, Carlos Fernández-Del Castillo.   

Abstract

Distal cholangiocarcinoma (malignancy in the common bile duct from the cystic duct to the ampulla) remains a rare diagnosis. Most of these lesions are adenocarcinomas, and typically present with painless jaundice. If suspected, a high-quality CT scan and endoscopic retrograde cholangiopancreatography are required for diagnosis and staging. In addition, identification of risk factors, use of tumor markers, and advanced molecular testing may enhance diagnostic and prognostic capabilities. The treatment of choice for resectable disease is pancreaticoduodenectomy and the overall 5-year survival for resected distal cholangiocarcinoma remains 20% to 30%.

Entities:  

Mesh:

Year:  2008        PMID: 18992603     DOI: 10.1016/j.suc.2008.07.003

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  7 in total

1.  A new variant of bile duct duplication with coexistence of distal cholangiocarcinoma.

Authors:  Ilkay Kosar; Hilmi Ataseven; Ozlem Yönem; Erol Cakmak; Ozdemir Ozer; Hatice Ozer; Omer Topçu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

2.  Distal extrahepatic cholangiocarcinoma presenting as cholangitis.

Authors:  Maximilian Lee; Subhas Banerjee; Mitchell C Posner; Christine A Cartwright
Journal:  Dig Dis Sci       Date:  2010-05-26       Impact factor: 3.199

3.  Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.

Authors:  Raul S Gonzalez; Pelin Bagci; Olca Basturk; Michelle D Reid; Serdar Balci; Jessica H Knight; So Yeon Kong; Bahar Memis; Kee-Taek Jang; Nobuyuki Ohike; Takuma Tajiri; Sudeshna Bandyopadhyay; Alyssa M Krasinskas; Grace E Kim; Jeanette D Cheng; N Volkan Adsay
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

Review 4.  The treatment of cholangiocarcinoma: a hepatologist's perspective.

Authors:  Kamran Qureshi; Randhir Jesudoss; Abdullah M S Al-Osaimi
Journal:  Curr Gastroenterol Rep       Date:  2014-10

5.  Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.

Authors:  Ioannis Hatzaras; Carl Schmidt; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  HPB (Oxford)       Date:  2010-03       Impact factor: 3.647

6.  Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.

Authors:  Yuichiro Kato; Shinichiro Takahashi; Naoto Gotohda; Masaru Konishi
Journal:  J Gastrointest Surg       Date:  2016-06-01       Impact factor: 3.452

7.  Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT.

Authors:  Youssef Elias; Aladin T Mariano; Yang Lu
Journal:  World J Nucl Med       Date:  2016-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.